Nanotechnology and dermatology: Part II-risks of nanotechnology

Clinics in Dermatology

Volumn 28, Issue 5, 2010, Pages 581-588

  Nasir, Adnan ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON BLACK; CARBON NANOTUBE; COSMETIC; GADOLINIUM; NANOMATERIAL; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; SOYBEAN OIL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ZINC;

ACNE; ALLERGENICITY; ATOPIC DERMATITIS; CONTACT DERMATITIS; DERMATOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EXPOSURE; EYE TOXICITY; FOREIGN BODY GRANULOMA; GASTROINTESTINAL TOXICITY; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; LIVER TOXICITY; LUNG FIBROSIS; LUNG TOXICITY; MYELOFIBROSIS; NANODEVICE; NANOEMULSION; NANOTECHNOLOGY; NEPHROTOXICITY; NEUROTOXICITY; NOTE; OXIDATIVE STRESS; PARENTERAL NUTRITION; PARTICLE SIZE; PRIORITY JOURNAL; RISK ASSESSMENT; SEBORRHEIC DERMATITIS; SKIN CARE; SKIN PENETRATION; SKIN PERMEABILITY; SQUAMOUS CELL METAPLASIA; TOXICITY TESTING;

DERMATOLOGY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; RESPIRATORY TRACT DISEASES; RISK; SKIN DISEASES;

EID: 77955941005     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.06.006     Document Type: Note

References (62)

1. Corbally M. Just visiting: memoirs of a health visitor 2001, Woodfield Publishing, West Sussex, UK.
2. Nel A., Xia T., Mädler L., Li N. Toxic Potential of materials at the nanolevel. Science 2006, 311:622-627.
3. Borm P.J., Robbins D., Haubold S., et al. The potential risks of nanomaterials: a review carried out for ECETOC. Particle Fibre Toxicol 2006, 3:11.
4. Brown D.M., Wilson M.R., MacNee W., Stone V., Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175:191-199.
5. Warheit D.B. Nanoparticles: health impacts?. Materials Today 2004, 7:32-35.
6. Araujo L., Lobenberg R., Kreuter J. Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Target 1999, 6:373-385.
7. Froehling D.A., Bowen J.M., Mohr D.N., et al. The canalith repositioning procedure for the treatment of benign paroxysmal positional vertigo: a randomized controlled trial. Mayo Clin Proc 2000, 75:695-700.
8. Oberdörster G., Gelein R.M., Ferin J., Weiss B. Association of particulate air pollution and acute mortality: involvement of ultrafine particles?. Inhal Toxicol 1995, 7:111-124.
9. Oberdörster G., Sharp Z., Atudorei V., et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543.
10. Oberdörster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol 1996, 8(suppl):73-89.
11. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
12. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
13. Oberdörster G. Toxicology of ultrafine particles: in vivo studies. Phil Trans Roy Soc London Series 2000, 358:2719-2740.
14. Oberdörster G., Maynard A., Donaldson K., et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005, 2:8.
15. Bermudez E., Mangum J.B., Wong B.A., et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004, 77:347-357.
16. Brown D.M., Donaldson K., Borm P.J., et al. Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am J Physiol Lung Cell Mol Physiol 2004, 286:L344-L353.
17. Hetland R.B., Cassee F.R., Refsnes M., et al. Release of inflammatory cytokines, cell toxicity and apoptosis in epithelial lung cells after exposure to ambient air particles of different size fractions. Toxicol In Vitro 2004, 18:203-212.
18. Cui D., Tian F., Ozkan C.S., Wang M., Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 2005, 155:73-85.
19. Bennat C., Muller-Goymann C.C. Characterization of skin penetration of microfine titanium dioxide used in sunscreen formulations 1998.
20. Lansdown A.B.G., Taylor A. Zinc and titanium oxides: promising UV-absorbers but what influences do they have on the intact skin?. Int J Cosmetic Science 1997, 19:167-172.
21. Monteiro-Riviere N.A., Riviere J.E. Skin toxicology. Toxicology 1999, 439-457. Academic Press, San Diego. H. Marquardt, S. Schafer, R. McCellan, F. Welsch (Eds.).
22. Qiao G.L., Brooks J.D., Riviere J.E. Pentachlorophenol dermal absorption and disposition from soil in swine: effects of occlusion and skin microorganism inhibition. Toxicol Appl Pharmacol 1997, 147:234-246.
23. Verma D.D., Verma S., Blume G., Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003, 258:141-151.
24. Walters K.A. Penetration enhancers and their use in transdermal therapeutic systems. Transdermal drug delivery: developmental issues and research initiatives 1989, 197-246. Marcel Dekker, New York. J. Hadgraft, R.H. Guy (Eds.).
25. Shaefer H., Lademann J. The role of follicular penetration: a differential view. Skin Pharmacol Appl Skin Physiol 2001, 14(suppl 1):23-27.
26. Beck-Speier I., Dayal N., Karg E., et al. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005, 38:1080-1092.
27. Monteiro-Riviere N.A., Nemanich R.J., Inman A.O., Wang Y.Y., Riviere J.E. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicol Lett 2005, 155:377-384.
28. Monteiro-Riviere N.A., Wang Y.Y., Hong S.M., et al. Proteomic analysis of nanoparticle exposure in human keratonicyte cell culture. Toxicologist 2005, 84:2183.
29. Sayes C.M., Gobin A.M., Ausman K.D., Mendez J., West J.L., Colvin V.L. Nano-C(60) cytotoxicity is due to lipid peroxidation. Biomaterials 2005, 26:7587-7595.
30. Shvedova A.A., Castranova V., Kisin E.R., et al. Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells. J Toxicol Environ Health A 2003, 66:1909-1926.
31. Schins R.P.F., Donaldson K. Nuclear factor kappa-B activation by particles and fibres. Inhal Toxicol 2000, 12:317-326.
32. Barlow P.G., Donaldson K., MacCallum J., Clouter A., Stone V. Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 2005, 155:397-401.
33. Nemmar A., Hoylaerts M.F., Hoet P.H., et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002, 166:998-1004.
34. Donaldson K., Tran L., Jimenez L.A., et al. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2006, 3:13.
35. Zhu Y., Hinds W.C., Krudysz M., Kuhn T., Froines J., Sioutas C. Penetration of freeway ultrafine particules into indoor environments. J Aerosol Sci 2005, 36:303-322.
36. Kreyling W.G., Semmler M., Erbe F., et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 2002, 65:1513-1530.
37. Semmler M., Seitz J., Erbe F., et al. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004, 16:453-459.
38. Shvedova A.A., Kisin E.R., Mercer R., et al. Unusual inflammatory and fibrogenic pulmonary responses to single walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289:L698-L708.
39. Li N., Sioutas C., Cho A., et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003, 111:455-460.
40. Li N., Wang M., Oberley T.D., Sempf J.M., Nel A.E. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J Immunol 2002, 169:4531-4541.
41. Bell M.L., Davis D.L. Reassessment of the lethal London fog of 1952: novel indicators of acute and chronic consequences of acute exposure to air pollution. Environ Health Perspect 2001, 109(suppl 3):389-394.
42. Bell M.L., Davis D.L., Fletcher T.F. A retrospective assessment of mortality from the London smog episode of 1952: the role of influenza and pollution. Environ Health Perspect 2004, 112:6-8.
43. Dockery D.W., Pope C.A. Acute respiratory effects of particulate air pollution. Ann Rev Public Health 1994, 15:107-132.
44. Hong Y.C., Lee J.T., Kim H., Kwon H.J. Air pollution: a new risk factor in ischemic stroke mortality. Stroke 2002, 33:2165-2169.
45. MacNee W., Donaldson K. How can ultrafine particles be responsible for increased mortality?. Monaldi Arch Chest Dis 2000, 55:135-139.
46. Oberdorster G., Sharp Z., Atudorei V., et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445.
47. Peters A., Dockery D.W., Muller J.E., Mittleman M.A. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001, 103:2810-2815.
48. Peters A., Wichmann H.E., Tuch T., Heinrich J., Heyder J. Respiratory effects are associated with the number of ultrafine particles. Am J Respir Critic Care Med 1997, 155:1376-1383.
49. Prescott G.J., Cohen G.R., Elton R.A., Fowkes F.G., Agius R.M. Urban air pollution and cardiopulmonary ill health: a 14.5 year time series study. Occup Environ Med 1998, 55:697-704.
50. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., Webb T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 2004, 77:117-125.
51. Calderón-Garcidueñas L., Reed W., Maronpot R.R., et al. Brain inflammation and Alzheimer's like pathology in individuals exposed to severe air pollution. Toxicol Pathol 2004, 32:650-658.
52. Jani P.U., Florence A.T., McCarthy D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharmaceut 1992, 84:245-252.
53. Jani P.U., McCarthy D.E., Florence A.T. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharmaceut 1994, 105:157-168.
54. Powell J.J., Harvey R.S., Ashwood P., Wolstencroft R., Gershwin M.E., Thompson R.P. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000, 14:99-105.
55. Corbin I.R., Li H., Chen J., et al. Low-Density Lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia 2006, 8:488-498.
56. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006, 21:1104-1108. [Erratum in: Nephrol Dial Transplant 2006;21:1745].
57. Marckmann P., Skov L., Rossen K., et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006, 17:2359-2362.
58. High W.A., Ayers R.A., Chandler J., Zito G., Cowper S.E. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007, 56:21-26.
59. Boyd A.S., Zic J.A., Abraham J.L. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007, 56:27-30.
60. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004, 12:635-641.
61. Oberdörster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004, 112:1058-1062.
62. Oberdörster G., Ferin J., Lehnert B.E. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102(suppl 5):173-179.